Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc.

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

September 1, 2023

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Curia Wisconsin, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 169 (Friday, September 1, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 169 (Friday, September 1, 2023)]
[Notices]
[Pages 60499-60500]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-18923]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1251]


Bulk Manufacturer of Controlled Substances Application: Curia 
Wisconsin, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Curia Wisconsin, Inc has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

[[Page 60500]]


DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
October 31, 2023. Such persons may also file a written request for a 
hearing on the application on or before October 31, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 3, 2023, Curia Wisconsin, Inc., 870 Badger 
Circle, Grafton, Wisconsin 53024-0000, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
            Controlled substance               Drug code     Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide..................        7315  I
Tetrahydrocannabinols.......................        7370  I
4-Bromo-2,5-dimethoxyphenethylamine.........        7392  I
3,4-Methylenedioxyamphetamine...............        7400  I
3,4-Methylenedioxymethamphetamine...........        7405  I
5-Methoxy-N-N-dimethyltryptamine............        7431  I
Dimethyltryptamine..........................        7435  I
Psilocybin..................................        7437  I
Psilocyn....................................        7438  I
Methylphenidate.............................        1724  II
Nabilone....................................        7379  II
ANPP (4-Anilino-N-phenethyl-4-piperidine)...        8333  II
Noroxymorphone..............................        9668  II
Fentanyl....................................        9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the purpose of analytical reference standards or for 
sale to its customers. In reference to the drug code 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture as 
synthetic. No other activities for these drug codes are authorized for 
this registration.

Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-18923 Filed 8-31-23; 8:45 am]
BILLING CODE P


</pre></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on September 1, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.